APA (7th ed.) Citation

Radkhah, H., Rahimipour Anaraki, S., Parhizkar Roudsari, P., Arabzadeh Bahri, R., Zooravar, D., Asgarian, S., . . . Khalooeifard, R. (2025). The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders. Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 30(1), . https://doi.org/10.1007/s40519-025-01720-9

Chicago Style (17th ed.) Citation

Radkhah, Hanieh, Shiva Rahimipour Anaraki, Peyvand Parhizkar Roudsari, Razman Arabzadeh Bahri, Diar Zooravar, Sara Asgarian, Reza Hosseini Dolama, Ali Alirezaei, and Razieh Khalooeifard. "The Impact of Glucagon-like Peptide-1 (GLP-1) Agonists in the Treatment of Eating Disorders." Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 30, no. 1 (2025). https://doi.org/10.1007/s40519-025-01720-9.

MLA (9th ed.) Citation

Radkhah, Hanieh, et al. "The Impact of Glucagon-like Peptide-1 (GLP-1) Agonists in the Treatment of Eating Disorders." Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, vol. 30, no. 1, 2025, https://doi.org/10.1007/s40519-025-01720-9.